Hot Papers

p.18 P. Vallance, J. Collier, S. Moncada, "Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man," Lancet, 2:997-1000, 1989. Joe Collier (St. George's Hospital Medical School, London): "The Clinical Pharmacology Unit at St. George's Hospital Medical School has a tradition of seeking to understand the local pharmacology of human peripheral vasculature both in health and in disease. Much of the early work on the peripheral actions (venous and arterial) of, for examp

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

p.18

P. Vallance, J. Collier, S. Moncada, "Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man," Lancet, 2:997-1000, 1989.

Joe Collier (St. George's Hospital Medical School, London): "The Clinical Pharmacology Unit at St. George's Hospital Medical School has a tradition of seeking to understand the local pharmacology of human peripheral vasculature both in health and in disease. Much of the early work on the peripheral actions (venous and arterial) of, for example, b-blockers, calcium antagonists, prostaglandins, and ACE inhibitors came from the unit, and so it was natural that we would become immersed in the EDRF [endothelium-derived relaxing

factor] story. Initial studies involving endothelial denudation of the dorsal hand veins, indicated that veins, at least, were capable of releasing nitric oxide. The advent of the NO-synthetase blocker L-NMMA allowed us to look at this effect in arteries, but, in this instance, by means of `pharmacological' denudation. We believe ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies